Just how many patients will benefit from the change continues to be a matter for debate. Federal health officials estimate that somewhere between 10,000 and 70,000 new patients may gain access to buprenorphine under the change in the first year. That is a relatively small increase compared with the roughly 650,000 patients the federal health agency estimates currently take the drug.